Biosimilars in Malaysia: Regulatory framework, approved products, and adverse effects
Introduction Biosimilars are a cost-effective alternative to original biologic medicines that allow patients access to biologic therapies for various chronic diseases. Our paper aims to provide an overview of biosimilars in Malaysia with emphasis on the comparison of Malaysian guidelines with guidel...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Published: |
Springer Heidelberg
2021
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/27080/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|